Skip to content
Screener

Abbott ABT Non-Controlling Interests

Non-Controlling Interests at other companies

Medtronic logo
MedtronicMDT
$609M+163%

Other financials

Income statement

See full
Revenue$12.6B+13.0%
Gross profit$7.3B+15.6%
Operating income$1.7B-17.5%
Net income$928.0M-47.8%
EPS (diluted)$0.53-47.5%

Balance sheet

See full
Cash & equivalents$5.1B-26.6%
Total debt$32.6B+143%
Total equity$51.1B+1.1%
Total assets$109.22B+30.0%

Cash flow

See full
Operating cash flow$2.5B+21.5%
CapEx$497.0M-1.0%
Free cash flow$2.0B+28.9%

Valuation

See full
Market cap$182.92B-19.7%
Enterprise value$210.42B-10.2%
P/E33.7×+17.4×
P/S3.9×-1.4×

Profitability

See full
Gross margin56.6%+0.6pp
Operating margin15.8%-1.7pp
Net margin11.6%-20.8pp
FCF margin16.8%+1.1pp

Returns & leverage

See full
Return on equity10.7%-20.4pp
Debt / equity0.6×+0.4×
Current ratio1.4×-0.4×

Where this comes from

Reported directly by Abbott in its filing.

Tagged under the XBRL concept us-gaap:MinorityInterest.

The source filing: Abbott’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 4:02 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-050134
Line itemJune 30,2026December 31,2025
Common shares, without par value Authorized — 2,400,000,000 shares Issued at stated capital amount — Shares: 2026: 1,998,291,279; 2025: 1,996,795,52525,49525,527
Common shares held in treasury, at cost — Shares: 2026: 267,907,258; 2025: 260,196,074(17,967)(17,177)
Earnings employed in the business49,79449,781
Accumulated other comprehensive income (loss)(6,212)(6,001)
Total Abbott Shareholders’ Investment51,11052,130
Noncontrolling interests652641
Total Shareholders’ Investment51,76252,771
$109,215$86,713

Item 1. Financial Statements and Supplementary Data

FAQ

What is Abbott's non-controlling interests?
Abbott (ABT) reported non-controlling interests of $652M in Q2 2026.
How has Abbott's non-controlling interests changed year-over-year?
Abbott's non-controlling interests increased by 147.0% year-over-year, from $264M to $652M.
What is the long-term trend for Abbott's non-controlling interests?
Over 5 years (2020 to 2025), Abbott's non-controlling interests has grown at a 24.0% compound annual growth rate (CAGR), from $219M to $641M.
What does non-controlling interests mean?
Equity attributable to minority shareholders in subsidiaries not fully owned by the parent — their proportional claim on subsidiary net assets.

Ask your AI about Abbott's non-controlling interests.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude